Use Ivermectin

Use Ivermectin

09/16/21- calls for Ivermectin to be deployed against COVID-19 calls for the FDA, NIH, CDC, and The White House to strongly recommend and widely deploy Ivermectin against COVID-19 for these 5 reasons.

1.  Ivermectin has ended the COVID-19 pandemic in other countries.

When the Delta variant arose in India, its most populous state Uttar Pradesh (population 220 million) gave Ivermectin to everyone who tested positive for COVID-19, as well as to all of their contacts. Uttar Pradesh State Surveillance Officer Vikssendu Agrawal stated, "Uttar Pradesh was the first state in the country to introduce large-scale prophylactic and therapeutic use of Ivermectin." ("Prophylactic" means preventively before infection, and "therapeutic" means as therapy after infection.) The number of new COVID-19 cases and deaths in Uttar Pradesh plummeted immediately thereafter and has remained at near zero since then even though only 7% of its population has been fully vaccinated as of September 15, 2021:

Uttar Pradesh Covid Ivermectin

Bihar, India's second most populous state, also used Ivermectin to crush the Delta variant outbreak in April of 2021 (source) despite only 7.4% of its 125 million people having been fully vaccinated (source). National Capital Territory (NCT) of Delhi, which includes the Indian capital, also used Ivermectin against the Delta variant, with the same result:

Delhi Covid Ivermectin

By contrast, the Indian states of Kerala restricted Ivermectin use, focused on vaccinating its 35 million people, and attained the highest vaccination rate among all Indian states with a population of at least 10 million. On July 29, August 27, and September 15, 2021, 50%, 67%, and 75%, respectively, of all new COVID-19 cases in India were in Kerala (source), which has only 3% of India's population (source).

Another set of states restricted Ivermectin use, focused on vaccination, and fully vaccinated 55% of its 330 million people against COVID-19. On September 15, 2021, those states, called the United States of America, had 167,868 new cases of and 2,544 new deaths from COVID-19.

The combined population of Uttar Pradesh and Bihar above is 345 million, which is larger than the US population. After widely deploying Ivermectin instead of the COVID-19 vaccines (7.1% combined full vaccination rate), Uttar Pradesh and Bihar on September 15, 2021 combined for 19 new cases of and 0 new deaths from COVID-19.

2.  Ivermectin has prevented the COVID-19 pandemic in other countries.

Medical researchers have compared COVID-19 morbidity (sickness) and mortality (death) rates in 31 African countries where Ivermectin was already used widely vs. 22 African countries where Ivermectin was not already used widely, and reported that the former had an 86% lower COVID-19 morbidity rate and an 89% lower COVID-19 mortality rate:

Morbidity Rate
Mortality Rate
Ivermectin not used widely (22 countries) 6,473 per million 122 per million
Ivermectin used widely (31 countries) 926 per million 14 per million
Reduction with Ivermectin usage -86% -89%

Ivermectin Use in Africa

3.  Ivermectin is safe.

In July of 2021, the cumulative administered doses of COVID-19 vaccines and Ivermectin both reached 3,700,000,000. The number of deaths and adverse effects reported for both, summarized below, indicate that the vaccines are 53325% more likely to kill compared to Ivermectin:


Ivermectin 1992 16 4,669 3.7 billion
COVID-19 Vaccines 2021 8,532 1,490,915 3.7 billion
Difference   +53325% +31832%  

4.  Ivermectin can be deployed immediately, widely, and cheaply.

Because Ivermectin is a generic drug made by companies across the world, it can be deployed immediately to everyone in the United States and around the world at a very low cost. The World Health Organization (WHO) buys Ivermectin for $0.01 per 3 mg tablet.

5.  Ivermectin is far better than Remdesivir, which the FDA, NIH and CDC promotes as a remedy for COVID-19.

See Ivermectin vs. Remdesivir.